Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1485 USD | -1.00% | +0.34% | -23.85% |
Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 05 | Transcript : CytoDyn Inc. - Special Call |
Financials (USD)
Sales 2022 | 0.27 | Sales 2023 | - | Capitalization | 239M |
---|---|---|---|---|---|
Net income 2022 | -211M | Net income 2023 | -79M | EV / Sales 2022 | 989,524,989 x |
Net Debt 2022 | 32.57M | Net Debt 2023 | 33.01M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
1 day | -1.00% | ||
1 week | +0.34% | ||
Current month | -9.06% | ||
1 month | -9.12% | ||
3 months | -9.95% | ||
6 months | -12.65% | ||
Current year | -23.85% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | Nov. 16 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | Jan. 31 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 22-10-12 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 22-08-23 |
Karen Brunke
BRD | Director/Board Member | 72 | 22-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.1485 | -1.00% | 648,615 |
24-04-23 | 0.15 | -0.07% | 423,580 |
24-04-22 | 0.1501 | -3.16% | 790,017 |
24-04-19 | 0.155 | +2.75% | 662,955 |
24-04-18 | 0.1508 | +3.32% | 806,934 |
Delayed Quote OTC Markets, April 24, 2024 at 03:55 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-23.85% | 149M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- CYDY Stock